What explains declining coronary mortality? Lessons and warnings
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
One of the most important health achievements during the 20th century was the unravelling of the causes of vascular diseases (CVDs). Developing the risk factor paradigm helped us to understand the unparalleled rise and fall in CVD mortality rates seen in many Western countries. Despite the substantial decrease in the past 40 years, CVD is still an important burden for societies across the world. Annually in the UK, there are 200 000 deaths from CVD (60 000 premature with health and social costs exceeding 30 billion.1 Dealing with this burden will be challenging. The US healthcare system is already facing economic crisis. Today’s planners require renewed efforts to control this disease. We are very fortunate, because this group of diseases has been extensively studied. We have detailed knowledge of its causation and what effects can come from evidence-based therapeutic interventions. Since the 1980s, coronary heart disease (CHD) mortality rates have halved in many developed countries and have fallen by 75% in countries like Finland.2 Comparable falls have also been seen in those Mediterranean countries with lower rates, such as France and Italy (fig 1).3 But are these achievements going to persist? S Capewell Figure 1 Changes in death rates from coronary heart disease, in men and women aged 35–74, between 1990 and 2000, selected countries. Source: Heartstats.3 Reproduced with permission of the copyright holder. Modern cardiovascular treatments have played an important role. The explosion in evidence-based treatments since the 1980s has provided us with tools to modestly increase life expectancy in those affected by disease. But it is important to recognise that about half of all CVD related deaths occur outside hospitals, usually before any emergency care can be offered. Furthermore, this is often the first manifestation of CVD.4 Treatments will play an important role in any future CVD strategy. However, our increasingly precise understanding of CHD causation suggests that most of the CHD disease burden can be attributed to modifiable lifestyle and dietary risk factors.5–7 Furthermore, …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Self-citation(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 1×
“Recent meta-analyses of high-quality cohorts help to validate the risk factor paradigm, and to inform increasingly precise measurement of effect sizes—a 50% CHD mortality decrease for 1 mmol/l reduction in cholesterol, or a 2% decrease for every 1 mm Hg reduction in systolic blood pressure.(12) 13”
Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002
Ford, E. S., & Capewell, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.056 · Cited by 589 · cited 1×
“young adults in England and Wales, the USA, New Zealand and Australia has recently been reported even though the overall trends are still decreasing.(17) 24–27 What does this mean? Are younger cohorts experiencing different levels of exposure to CVD determinants, perhaps associated with the known increasing unfavourab…”
BackgroundSelf-citationMenotti, A., Lanti, M., Kromhout, D., Blackburn, H., Nissinen, A., Dontas, A., Kafatos, A., Nedeljkovic, S., & Adachi, H. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9176-4 · Cited by 61
Cited by
Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?
Mc Namara, K., Alzubaidi, H., & Jackson, J. K. (2019) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s133088 · Cited by 410
Trends in European life expectancy: a salutary view
Leon, D. A. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr061 · Cited by 316
Wijeysundera, H. C. (2010) · JAMA · doi:10.1001/jama.2010.580 · Cited by 312
Coronary heart disease epidemics: not all the same
Mirzaei, M., Truswell, A. S., Taylor, R., & Leeder, S. R. (2009) · Heart · doi:10.1136/hrt.2008.154856 · Cited by 135
Intermittent fasting for the prevention of cardiovascular disease
Allaf, M., Elghazaly, H., Mohamed, O. G., Fareen, M. F. K., Zaman, S., Salmasi, A.-M., Tsilidis, K., & Dehghan, A. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013496.pub2 · Cited by 98
Metadata
- Authors
- Capewell, S., & O’Flaherty, M.
- Venue
- Heart
- Publisher
- BMJ
- Published
- 2008-08-14
- Volume
- 94
- Issue
- 9
- Pages
- 1105-1108
- ISSN
- 1355-6037 (ISSN-L)
- 1468-201X
- OpenAlex
- W2046095804
- Cited by
- 53
- References
- 4
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What explains declining coronary mortality? Lessons and warnings. https://app.cochat.ai/papers/10.1136/hrt.2008.149930
- The paper
- Capewell, S., & O’Flaherty, M. (2008). What explains declining coronary mortality? Lessons and warnings. Heart. https://doi.org/10.1136/hrt.2008.149930
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.